Testosterone in Metastatic Renal Cell Carcinoma Patients
NCT03379012
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Renal Cell Carcinoma
Interventions
DRUG:
Testosterone undecanoate and sunitinib or pazopanib
Sponsor
Kidney Cancer Research Bureau